GlassScriptPhysician profile
Kyle Penland
NPI 1821611534
$446.91
in general payments reported to CMS, 2019-2025
8 companies · $209 in 2025
The $209 reported for 2025 was more than what 76% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.95 · 2022: $86.06 · 2023: $11.69 · 2024: $107 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288 · Education: $38.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.25 |
| Education | $38.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $268.75 | 2022-2025 | Invisalign |
| Orapharma, A Division of Bausch Health US, LLC | $63.02 | 2022-2024 | Arestin |
| Envista Holdings Corporation | $38.65 | 2024 | Nexus Rmgi |
| Nobel Biocare USA | $20.05 | 2020 | |
| Dentsply Sirona INC | $19.69 | 2022 | |
| 3m Company | $13.90 | 2020 | |
| Voco America INC. | $11.69 | 2023 | Admira Fusion X-Tra, Futurabond U, Voco Profluorid Varnish |
| Ultradent Products INC | $11.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Penland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.